Breakthrough innovations in medical research and discovery now dictate the use of cryo preservation, transportation, and storage solutions for therapies that treat chronic and terminal diseases. For years the pharmaceutical industry has been excited about “personalized medicine” to save lives. And recent, innovative medical research is making the dream a reality. Regenerative therapies, immunotherapies, autologous treatments, and allogeneic stem cell discoveries have created treatment protocols that require strict temperature stability.
The manufacturing process for these therapies is complex and usually requires tissue or blood from the patient to make the treatment. Most of the time, there is a single manufacturing facility that serves a global patient population. Traditional shipping solutions such as dry ice not only present hazardous material and handling risks, but the temperature instability can lead to the loss of the cells required to make the treatment.
Cryoport, the leading provider of deep-frozen solutions for shipping and storage for the life sciences industry, understands the importance of temperature stability and patient safety. The Cryoport solutions combine the technology of liquid nitrogen dry vapor shippers with the most advanced logistics management platform in the industry to replace outdated dry ice shipping.
... to continue reading you must be subscribed
